Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase

Journal of Molecular and Cellular Cardiology

Volumn 36, Issue 4, 2004, Pages 505-513

  Ma, Kenneth K ^a   Ogawa, Tsuneo ^a   De Bold, Adolfo J ^a,b  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Atrial natriuretic factor; Brain natriuretic peptide; Cytokines; Heart transplantation; Signal transduction

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CYTOKINE; INTERLEUKIN 1BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HEART TRANSPLANTATION; HISTOCOMPATIBILITY; LYMPHOCYTE CULTURE; MIXED LYMPHOCYTE REACTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; STATISTICAL SIGNIFICANCE; UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYTOKINES; DENSITOMETRY; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; IMIDAZOLES; INFLAMMATION; INTERFERON TYPE II; INTERLEUKIN-1; LYMPHOCYTES; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDES; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTEIN BIOSYNTHESIS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSPLANTATION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 1842715076     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2004.01.001     Document Type: Article

References (21)

1. Masters R.G., Davies R.A., Keon W.J., Walley V.M., Koshal A., de Bold A.J. Neuroendocrine response to cardiac transplantation. Can J Cardiol. 9:(7):1993;609-617.
2. Masters R.G., Davies R.A., Veinot J.P., Hendry P.J., Smith S.J., de Bold A.J. Discoordinate modulation of natriuretic peptides during acute cardiac allograft rejection in humans. Circulation. 100:(3):1999;287-291.
3. Ogawa T., Vatta M., Bruneau B.G., de Bold A.J. Characterization of natriuretic peptide production by adult heart atria. Am J Physiol. 276:(6 Pt 2):1999;H1977-H1986.
4. de Bold A.J., Bruneau B.G., Kuroski de Bold M.L. Mechanical and neuroendocrine regulation of the endocrine heart. Cardiovasc Res. 31:(1):1996;7-18.
5. Cunningham D.A., Dunn M.J., Yacoub M.H., Rose M.L. Local production of cytokines in the human cardiac allograft. A sequential study. Transplantation. 57:(9):1994;1333-1337.
6. Duquesnoy R.J., Demetris A.J. Immunopathology of cardiac transplant rejection. Curr Opin Cardiol. 10:(2):1995;193-206.
7. Argentin S., Ardati A., Tremblay S., Lihrmann I., Robitaille L., Drouin J., et al. Developmental stage-specific regulation of atrial natriuretic factor gene transcription in cardiac cells. Mol Cell Biol. 14:(1):1994;777-790.
8. Sarda I.R., de Bold M.L., de Bold A.J. Optimization of atrial natriuretic factor radioimmunoassay. Clin Biochem. 22:(1):1989;11-15.
9. Yokota N., Bruneau B.G., Fernandez B.E., de Bold M.L., Piazza L.A., Eid H., et al. Dissociation of cardiac hypertrophy, myosin heavy chain isoform expression, and natriuretic peptide production in DOCA-salt rats. Am J Hypertens. 8:(3):1995;301-310.
10. Grepin C., Dagnino L., Robitaille L., Haberstroh L., Antakly T., Nemer M. A hormone-encoding gene identifies a pathway for cardiac but not skeletal muscle gene transcription. Mol Cell Biol. 14:(5):1994;3115-3129.
11. Murase N., Demetris A.J., Woo J., Tanabe M., Furuya T., Todo S., et al. Graft-versus-host disease after brown Norway-to-Lewis and Lewis-to-Brown Norway rat intestinal transplantation under FK506. Transplantation. 55:(1):1993;1-7.
12. Gersten M.J., Cohn M. A defined basal medium for study of in vitro T-cell responses. Cell Immunol. 91:(1):1985;143-158.
13. Mann D.L. Recent insights into the role of tumor necrosis factor in the failing heart. Heart Fail Rev. 6:(2):2001;71-80.
14. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallagher T.F., et al. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:(2):1995;229-233.
15. Zhao X.M., Frist W.H., Yeoh T.K., Miller G.G. Expression of cytokine genes in human cardiac allografts: correlation of IL-6 and transforming growth factor-beta (TGF-beta) with histological rejection. Clin Exp Immunol. 93:(3):1993;448-451.
16. Darnell J.E. Jr. Studies of IFN-induced transcriptional activation uncover the Jak-Stat pathway. J Interferon Cytokine Res. 18:(8):1998;549-554.
17. Zeevi A., Chiu K.M., Duquesnoy R.J. Functional differences between cells from MLR colonies grown in soft agar cultures. J Immunol. 125:(3):1980;1130- 1135.
18. Tamura N., Ogawa Y., Chusho H., Nakamura K., Nakao K., Suda M., et al. Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc Natl Acad Sci USA. 97:(8):2000;4239-4244.
19. Ogawa Y., Tamura N., Chusho H., Nakao K. Brain natriuretic peptide appears to act locally as an anti-fibrotic factor in the heart. Can J Physiol Pharmacol. 79:(8):2001;723-729.
20. Kapadia S., Dibbs Z., Kurrelmeyer K., Kalra D., Seta Y., Wang F., et al. The role of cytokines in the failing human heart. Cardiol Clin. 16:(4):1998;645-656. viii.
21. Bryant D., Becker L., Richardson J., Shelton J., Franco F., Peshock R., et al. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation. 97:(14):1998;1375-1381.